Taken together, the key findings obtained from this study suggested the potential effect of GP treatment on restricting oxidative stress of CUMS-induced mice with depression-like behavior by upregulating Six3os1 through regulation of miR-511-3p-dependent Fezf1/AKT axis (Figure 7). This evidence concerns the gene FEZF1 and depressive symptom measurement.